scholarly journals Towards a Better Characterisation of Leukemic Cells in Chronic Lymphocytic Leukaemia: Cell-Size Heterogeneity Reflects Their Activation Status and Migratory Abilities

Cancers ◽  
2021 ◽  
Vol 13 (19) ◽  
pp. 4922
Author(s):  
Gayane Manukyan ◽  
Zuzana Mikulkova ◽  
Peter Turcsanyi ◽  
Jakub Savara ◽  
Markéta Trajerová ◽  
...  

Chronic lymphocytic leukaemia (CLL) is a genetically, morphologically and phenotypically heterogeneous chronic disease with clinical variability between patients. Whether the significant heterogeneity of cell size within the CLL population contributes to the heterogeneous features of this disease has not been investigated. The present study aimed to characterise the phenotypic and functional properties of two subpopulations of typical CLL cells that differ in cell size: small (s-CLL) and large (l-CLL) CLL cells delineated by forward scatter cytometry. The s-CLL cells were characterised by the CD5lowCXCR4hi phenotype, while the l-CLL cells were characterised by the CD5hiCXCR4dim phenotype and indicated a higher expression of CXCR3, CD20, CD38 and HLA-DR. The l-CLL cells displayed higher migration activity towards CXCL12, a tendency towards a higher proliferation rate and an increased capacity to produce IgM in the presence of CpG compared with s-CLL cells. When stimulated with CpG and CXCL12, l-CLL cells were characterised by a higher polarisation phenotype and motility than s-CLL cells. Our study revealed that the differences in CLL cell size reflected their activation status, polarisation and migratory abilities. Our data provide evidence of the importance of cell-size heterogeneity within a CLL pool and the dynamics of cell-size changes for disease pathogenesis, thus deserving further investigation.

Blood ◽  
2004 ◽  
Vol 104 (11) ◽  
pp. 4800-4800
Author(s):  
Achille Ambrosetti ◽  
Roberta Zanotti ◽  
Marco Chilosi ◽  
Flavia Zanetti ◽  
Maurizio Lestani ◽  
...  

Abstract New biological prognostic factors have been developed over the last years with the aim of predicting at presentation the heterogeneous clinical course of B chronic lymphocytic leukaemia (B-CLL) and of planning a risk-adapted treatment strategy. Among them ZAP-70 expression on leukemic cells as evaluated by molecular analysis or flow cytometry, initially proposed as surrogate of IgVH mutational status, appears a strong prognostic marker in B-CLL. However the optimal methodological approach to immunophenotipical demonstration of ZAP-70 expression as still matter of debate. We evaluated the cytoplasmic expression of ZAP-70 protein in leukemic cells by immunohistochemical method on bone marrow trephine biopsies taken at diagnosis of 84 patients with B-CLL. We used a mouse anti-human monoclonal antibody to ZAP-70 (clone 2F3.2, 1/200, Upstate, Lake Placid NY) with a polymeric labelling two-step method (Dako cytomation EnVision+, HRP). The results were correlated with age, sex, Binet stage, pattern of bone marrow infiltration, survival and clinical outcome. They were 54 males (64%), aged 34 to 80 years (median 62.5). At presentation 69 (82%) were Binet stage A, 9 (11%) stage B and 6 (7%) stage C. Among the 60 survivors, the median follow-up period from diagnosis was 78.5 months (range 22 – 236 months) Thirty-nine cases (46%) of B-CLL patients had cytoplasmic expression of ZAP-70. This group of patients presented higher percentage of advanced Binet stage (B–C) (p= 0.001). The ZAP-70 positivity was significantly related to inferior OS (55% vs 90% at 7 years)(HR 4.67 CI 1.95–11.14) and PFS (15% vs 57% at 7 years) (HR 5.52 CI 2.57–11.86), confirmed in multivariate analysis. ZAP-70 expression was correlated to poorer outcome also when we evaluated only the 69 stage A patients and the 56 cases with non-diffuse bone marrow infiltration, whereas in patients with diffuse pattern ZAP-70 expression had no prognostic significance. In conclusion, immunohistological detection of ZAP-70 on bone marrow samples at diagnosis appears a useful methodological approach to identify patients with different prognosis in B-CLL.


2003 ◽  
Vol 44 (5) ◽  
pp. 797-800 ◽  
Author(s):  
Sameer Manocha ◽  
Zoltan Matrai ◽  
Michael Osthoff ◽  
Anthony Carter ◽  
Andrew R. Pettitt

2009 ◽  
Vol 55 (1) ◽  
pp. 33-41 ◽  
Author(s):  
George Katrinakis ◽  
Despina Kyriakou ◽  
Michael Alexandrakis ◽  
Dimitra Sakellariou ◽  
Andreas Foudoulakis ◽  
...  

1982 ◽  
Vol 205 (1) ◽  
pp. 167-171 ◽  
Author(s):  
G T Williams ◽  
A P Johnstone ◽  
P D Dean

Detergent-solubilized plasma-membrane proteins from lymphocytes of patients with chronic lymphocytic leukaemia were applied to phenylboronic acid-agarose. Some of the polypeptides were bound specifically and subsequently eluted with sorbitol. Immunoprecipitation analyses showed that no surface immunoglobulin M was bound, but that most of the histocompatibility antigens HLA-A, HLA-B, HLA-C and HLA-DR were.


2018 ◽  
Vol 22 (7) ◽  
pp. 3548-3559 ◽  
Author(s):  
Emilia Białopiotrowicz ◽  
Patryk Górniak ◽  
Monika Noyszewska‐Kania ◽  
Bartosz Puła ◽  
Hanna Makuch‐Łasica ◽  
...  

PLoS ONE ◽  
2015 ◽  
Vol 10 (6) ◽  
pp. e0130195 ◽  
Author(s):  
Andreas Agathangelidis ◽  
Lydia Scarfò ◽  
Federica Barbaglio ◽  
Benedetta Apollonio ◽  
Maria Teresa Sabrina Bertilaccio ◽  
...  

PLoS ONE ◽  
2015 ◽  
Vol 10 (7) ◽  
pp. e0134748
Author(s):  
Andreas Agathangelidis ◽  
Lydia Scarfò ◽  
Federica Barbaglio ◽  
Benedetta Apollonio ◽  
Maria Teresa Sabrina Bertilaccio ◽  
...  

PLoS ONE ◽  
2021 ◽  
Vol 16 (7) ◽  
pp. e0254853
Author(s):  
Zsuzsa Nagy-Baló ◽  
Richárd Kiss ◽  
Judit Demeter ◽  
Csaba Bödör ◽  
Zsuzsa Bajtay ◽  
...  

Chronic lymphocytic leukaemia (CLL) is the most common leukaemia in the western world. In previous studies, various proportion of patients was found to carry CD11b+ or CD11c+ B cells whose presence was an unfavourable prognostic factor. The exact mechanism however, how these receptors contribute to the pathogenesis of CLL has not been revealed so far. Here we analysed the role of CD11b and CD11c on B cells of CLL patients in the adhesion to fibrinogen and in the migration towards stromal cell derived factor-1 (SDF-1) and studied the role of CR4 in the adherence of the CD11c+ B cell line BJAB. We observed that both CR3 and CR4 mediate adhesion of the malignant B cells. Moreover, we found, that CR4 was strongly involved in the migration of the leukemic cells towards the chemoattractant SDF-1. Our data suggest that CR3 and CR4 are not only passive markers on CLL B cells, but they might contribute to the progression of the disease. Since the role of SDF-1 is prominent in the migration of CLL cells into the bone marrow where their survival is supported, our findings help to understand how the presence of CD11c on leukemic B cells can worsen the prognosis of chronic lymphocytic leukaemia.


2003 ◽  
Vol 10 (3) ◽  
pp. 383-385 ◽  
Author(s):  
M F Romano ◽  
M Festa ◽  
G Pagliuca ◽  
R Lerose ◽  
R Bisogni ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document